Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
200
Trial Sponsor
Clinical Trial Start Date
October 3, 2018
0Primary Completion Date
November 9, 2018
0Study Completion Date
November 19, 2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Vadadustat0
Rabeprazole0
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Fixed Sequence, Open-label Study in Healthy Adult Subjects to Evaluate the Effect of Multiple Doses of Rabeprazole on the Pharmacokinetics of a Single Dose of Vadadustat0
Last Updated
March 22, 2019
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
This is a Phase 1, fixed sequence, open-label study to evaluate the effect of multiple oral doses of rabeprazole on the pharmacokinetics of a single dose of vadadustat 300 mg in healthy male and female subjects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
